Education
About Us
Working with TipRanks
Follow Us
Protara Therapeutics (TARA)
NASDAQ:TARA
Protara Therapeutics (TARA) Ownership Overview
9.22% Insiders
4.06% Mutual Funds
43.67% Other Institutional Investors
4.32% ETFs
38.73% Public Companies and Individual Investors
The ownership structure of Protara Therapeutics (TARA) stock is a mix of institutional, retail, and individual investors. Approximately 52.05% of the company’s stock is owned by Institutional Investors, 9.22% is owned by Insiders, and 38.73% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
May 16, 2025 | xxxxxxxxxxxxx | $63800 | |
Sep 12, 2024 | xxxxxxxxxxxxx | $270458 | |
Sep 10, 2024 | xxxxxxxxxxxxx | $113850 | |
Jul 18, 2024 | xxxxxxxxxxxxx | $27806 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $1160176 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $3628131 | |
Mar 31, 2025 | xxxxxxxxxxxxx | $7429618 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,400,000 | Institution | 8.81% | 10,846,000 | |
| 1,989,134 | Insider | 5.16% | 6,345,337 | |
| 1,744,042 | Institution | 4.52% | 5,563,494 | |
| 1,552,659 | Institution | 4.02% | 4,952,982 | |
| 1,319,896 | Institution | 3.42% | 4,210,468 | |
| 994,022 | Insider | 2.58% | 3,170,930 | |
| 851,674 | Institution | 2.21% | 2,716,840 | |
| 536,832 | Institution | 1.39% | 1,712,494 | |
| 272,342 | Institution | 0.71% | 868,771 | |
| 198,000 | Insider | 0.51% | 631,620 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,319,896 | Institution | 3.42% | 4,210,468 | |
| 155,930 | Institution | 0.40% | 497,417 | |
| 29,769 | Institution | 0.08% | 94,963 | |
| 25,000 | Institution | 0.06% | 79,750 | |
| 20,334 | Institution | 0.05% | 64,865 | |
| 16,636 | Institution | 0.04% | 53,069 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,023,901 | Institution | 2.65% | 3,583,654 | |
| 528,758 | Institution | 1.37% | 1,850,653 | |
| 52,515 | Institution | 0.14% | 163,322 | |
| 36,976 | Institution | 0.10% | 117,953 | |
| 5,845 | Institution | 0.02% | 18,178 | |
| 5,784 | Institution | 0.01% | 17,988 | |
| 4,453 | Institution | 0.01% | 13,849 | |
| 3,236 | Institution | <0.01% | 10,064 | |
| 2,484 | Institution | <0.01% | 7,725 | |
| 2,430 | Institution | <0.01% | 7,752 |
FAQ
Who Owns Protara Therapeutics (TARA)?
According to the latest TipRanks data, approximately 43.67% of the company's stock is held by institutional investors, 9.22% is held by insiders, and 38.73% is held by retail investors.
What percentage of Protara Therapeutics (TARA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 43.67% of Protara Therapeutics (TARA) stock is held by institutional investors.
What percentage of Protara Therapeutics (TARA) stock is held by retail investors?
According to the latest TipRanks data, approximately 38.73% of Protara Therapeutics (TARA) stock is held by retail investors.
Who owns the most shares of Protara Therapeutics (TARA)?
Peter Kolchinsky owns the most shares of Protara Therapeutics (TARA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.